Skip to main content
. 2018 Aug 21;5(2):139–146. doi: 10.1159/000491580

Fig. 2.

Fig. 2

Retinoblastoma managed with intra-arterial chemotherapy (IAC) plus intravitreal chemotherapy. a Group D retinoblastoma in a 24-month-old female demonstrated tumor regression (b) following one cycle of IAC with melphalan and 6 intravitreal melphalan injections. c Group D retinoblastoma in a 20-month-old male showed tumor regression (d) following four cycles of IAC with melphalan and topotecan plus 6 intravitreal melphalan injections.